RepliCel Life Sciences Gross margin
What is the Gross margin of RepliCel Life Sciences?
The Gross margin of RepliCel Life Sciences, Inc. is 100.00%
What is the definition of Gross margin?
Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.
lfy (last fiscal year)
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Gross margin of companies in the Health Care sector on TSXV compared to RepliCel Life Sciences
What does RepliCel Life Sciences do?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Companies with gross margin similar to RepliCel Life Sciences
- Zenkoku Hosho Co has Gross margin of 99.99%
- Damartex SA has Gross margin of 100.00%
- Consolidated Finvest & has Gross margin of 100.00%
- McDowell has Gross margin of 100.00%
- Vanguard Specialized Funds - Vanguard Real Estate ETF has Gross margin of 100.00%
- BlackRock MuniVest Fund has Gross margin of 100.00%
- RepliCel Life Sciences has Gross margin of 100.00%
- CRCAM Loire Haute-Loire has Gross margin of 100.00%
- iShares Trust - iShares Core S&P 500 ETF has Gross margin of 100.00%
- Clean Power Capital has Gross margin of 100.00%
- Investec plc has Gross margin of 100.00%
- Atlas Mara has Gross margin of 100.00%
- Huarong International has Gross margin of 100.00%